Analyst consensus rating
AC Immune Analyst Rating: none
Direct answer
AC Immune's consensus rating is none.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $8.73.
Forecast evidence checked November 5, 2026.
Get free AC Immune email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.05
- Average price target
- $8.73
- High price target
- $12.15
- Low price target
- $5.47
- Low target gap
- +166.7%
- Target upside
- +325.8%
- High target gap
- +492.6%
- Target range width
- 325.9%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- November 5, 2026
- Valid through
- November 12, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for AC Immune?
AC Immune has a verified none consensus. The same dataset has an average price target of $8.73.
How far are AC Immune's low and high targets from the recorded price?
The low target implies +166.7%, while the high target implies +492.6%.
How many analysts are included in AC Immune's consensus?
The verified consensus includes 4 analysts.
How is AC Immune's target upside or downside calculated?
The average target of $8.73 is divided by the recorded price of $2.05, then one is subtracted to produce +325.8%. This does not guarantee a future return.
When was AC Immune's analyst forecast verified?
The data was verified on 2026-11-05. The dataset is valid through 2026-11-12.